Lundbeck Canada is a subsidiary of H. Lundbeck A/S, an international research-based pharmaceutical company which focuses on diseases of the Central Nervous System. Based in Montreal, Lundbeck Canada has been part of the Canadian pharmaceutical industry for more than a decade and markets products for the treatment of depression, anxiety, Alzheimer’s Disease, and schizophrenia.  Through original research and development as well as in-licensing agreements with other companies, we are fulfilling our mission to improve the quality of life for those suffering from psychiatric and neurological disorders.